Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round
Samsara Inc.’s $805 Million Initial Public Offering
Freshfields advised Morgan Stanley on the deal while Wilson Sonsini Goodrich & Rosati represented Samsara. Morgan Stanley acted as representative of the underwriters on the initial...